Advertisement

The Hydrus Micro-stent

  • Shakeel Shareef
  • Antonio Fea
  • Iqbal Ike K. AhmedEmail author
Chapter

Abstract

The Hydrus micro-stent (Ivantis, Irvine CA) is a novel Schlemm’s canal microinvasive glaucoma surgery (MIGS) device designed to enhance aqueous outflow into Schlemm’s canal and into the distal outflow veins. Made of flexible nitinol, an elastic nickel-titanium alloy, the device is designed to conform to the arc of Schlemm’s canal (Fig. 15.1). The proximal end is designed to provide a bypass inlet into the canal, with the main body of the implant designed to act as an intracanalicular scaffold which dilates the canal nine times its cross-sectional area for a length of 8mm or 3 clock hours in the eye. It has a non-luminal design to provide unimpeded access of aqueous to the collector channels and aqueous veins along the back wall of the canal, and three windows face the inner wall to stretch and increase the effective filtration area. The Hydrus thus is designed to address the underlying pathology in open-angle glaucoma – increased resistance in the inner wall and collapse of Schlemm’s canal – by creating a bypass through the inner wall and stretching the inner wall as well as scaffolding open the canal and preventing collapse (Figs. 15.2 and 15.3). The device is implanted using a handheld injector through a sub 2.0 mm clear cornea incision using a specially designed cannula to incise the inner wall to permit deployment of the device using a roller wheel (Fig. 15.4). Although the device may be implanted in any clock hour in the canal, it is most readily performed in the nasal quadrant using a temporal corneal incision. The device is currently an investigational device and an FDA pivotal trial is underway. There already have been a number of basic science and early clinical studies on the Hydrus device.

Keywords

Roller Wheel Aqueous Outflow Outflow Facility Peripheral Anterior Synechia Nasal Quadrant 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Supplementary material

Video 15.1

Surgical technique of Hydrus micro-stent implantation within the nasal Schlemm’s canal in a phakic eye (MOV 68146 kb)

References

  1. 1.
    Grierson I. In vivo biocompatibility evaluation of a novel nickel-titanium Schlemm’s canal scaffold. Presented at the American Glaucoma Society annual meeting. New York City; Mar 2012.Google Scholar
  2. 2.
    Saheb H. A novel Schlemm’s canal scaffold maintains patency of collector cannel Ostia in human anterior segments. Presented at the American Glaucoma Society annual meeting. New York City; Mar 2012.Google Scholar
  3. 3.
    Camras LJ, Yuan F, Fan S, Samuelson TW, Ahmed IK, Schieber AT, Toris CB. A novel Schlemm’s canal scaffold increases outflow facility in a human anterior segment perfusion model. Invest Ophthalmol Vis Sci. 2012;53:6115–21.PubMedCrossRefGoogle Scholar
  4. 4.
    Gulati V, Fan S, Hays CL, Samuelson TW, Ahmed IIK, Toris CB. A novel 8-mm Schlemm’s canal scaffold reduces outflow resistance in a human anterior segment perfusion model. Invest Ophthalmol Vis Sci. 2013;54:1698–704.PubMedCrossRefGoogle Scholar
  5. 5.
    Gong H. Characterization of aqueous outflow through a novel Schlemm’s canal scaffold – a tracer study. Presented at the American Glaucoma Society annual meeting. New York City; Mar 2012.Google Scholar
  6. 6.
    Saheb H, Jampel H, Ahmed IK. One year outcomes of a Schlemm’s canal microstent for IOP reduction after cataract surgery in mild to moderate open angle glaucoma. Presented at the American Glaucoma Society annual meeting. San Francisco; Mar 2013.Google Scholar
  7. 7.
    Tetz M. 12 month results from a prospective, multicenter study of a nickel-titanium Schlemm’s canal microstent for IOP reduction after cataract surgery in open angle glaucoma. Presented at European Society of Cataract and Refractive Surgeons annual meeting. Milan; Sep 2012.Google Scholar
  8. 8.
    Samuelson T. One-year results of a Schlemm’s canal microstent for IOP reduction in open angle glaucoma. Presented at American Academy of Ophthalmology annual meeting. Chicago; Nov 2012.Google Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Shakeel Shareef
    • 1
  • Antonio Fea
    • 2
  • Iqbal Ike K. Ahmed
    • 3
    Email author
  1. 1.Flaum Eye InstituteUniversity of Rochester Medical Center, School of Medicine and DentistryRochesterUSA
  2. 2.Clinica Oculistica-Universita’ di Torino, Ospedale OftalmicoTorinoItaly
  3. 3.Department of Ophthalmology and Vision SciencesUniversity of TorontoTorontoCanada

Personalised recommendations